MedPath

The feasibility and potential efficacy of adding Tobacco Treatment using EMDR (ToTEM) to a regular smoking cessation program;A pilot randomized controlled trail in inpatient daily smokers with a substance use disorder

Completed
Conditions
Verslaving (stoornis in het gebruik van tabak)
smoking addiction
Tobacco use disorder
Registration Number
NL-OMON53586
Lead Sponsor
IrisZorg
Brief Summary

Trial is onging in other countries

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
1
Inclusion Criteria

- Diagnosis of Tobacco Use Disorder according to the DSM-5 (American
Psychiatric Association, 2013) criteria.
- Age >= 18 years.
- Good Dutch language proficiency (based on clinical judgement).
- Smoking, on average, >= 10 cigarettes per day pre-admission.
- A score of at least 5 on a scale from 0 to 10, for motivation and
self-efficacy
- A planned inpatient stay of >= 4 weeks.
- Written informed consent.

Exclusion Criteria

- Serious therapy interfering behavior or symptoms that also interfere with
TAU, based on clinical judgement (e. g. psychiatric or medical crisis that
requires immediate intervention).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study parameters/endpoints<br /><br>o The retention of participants from randomization until the last follow-up.<br /><br>o The acceptability of AF-EMDR to participants in terms of compliance, measured<br /><br>by the total number of sessions attended and the proportion of attended versus<br /><br>non attended (planned) sessions; a higher proportion of attended sessions<br /><br>reflects better compliance.<br /><br>o The acceptability of AF-EMDR to therapists in terms of adherence to the<br /><br>protocol, measured by the score of an independent rater on an a-priori<br /><br>established adherence rating protocol; a higher score reflects better<br /><br>adherence.</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath